ESTEVE OPENS NEW CORPORATE HEADQUARTERS
As announced in September 2017, ESTEVE has moved the 400+ people who so far worked at company sites scattered across Barcelona to the new corporate headquarters located at the Zona Franca.
ESTEVE occupies 10 of the 13 stories of the Esteve Tower, a building that is part of the new business area of Barcelona where Iberdrola Inmobiliaria promotes 4 buildings: Torre Auditori, Torre Esteve, Torre Ponent, and Torre Llevant.
This move fulfills the long-sought-after goal of centralizing all work centers in a single site. One of the requirements for this move was selling the historic corporate headquarters at the quarter of Guinardó (Barcelona), a transaction that was finally part of the same global agreement reached with Iberdrola.
Team concentration at a single work center will help accelerate digitization, promote more aligned, collaborative, cross-cutting work, and encourage innovation.
The new building provides a structure that combines bright and open spaces with excellent finishing details. In addition, the Esteve Tower has a Class A Energy Performance Certificate and a "Very good" BREEAM rating, and stands out for its functionality, sustainability and energy savings, thus making this office complex a unique and sustainable business center in Barcelona.
New Sustainability Report
ESTEVE has just published its Sustainability Report with 2017 activity data in the economic, social and environmental fields, a document endorsed by the Global Report Initiative (GRI), entity an independent international that leads and fosters the development by companies of transparent and verifiable information.
ESTEVE’S RDI, AGAIN RATED ’EXCELLENT’ BY THE PROFARMA PLAN
The Profarma Plan (Plan for the Promotion of Scientific Research, Development and Technological Innovation in the Pharmaceutical Industry), a joint program of the Ministry of Industry, Energy and Tour...read more
DIABETIC RETINOPATHY HAS TRIPLED OVER THE LAST 15 YEARS
This disease is one of the main causes of affiliation to the ONCE and the leading cause of blindness in the working age population of industrialized countries1read more
As of 20 years having type...
PHARMACEUTICAL ASSISTANCE IN SOCIO-MEDICAL CENTERS IS KEY TO THE CONTINUUM OF CARE PROVIDED TO MULTICONDITION PATIENTS
The data of a survey on pharmaceutical provision to socio-medical centers of Andalusia was presented at this meetingread more
This survey is based on the piloting of Decree 512/2015 initiated by t...